2004

DOI: 10.1200/jco.2004.22.90140.4748

|View full text |Cite

|

Sign up to set email alerts

|

C-BOP-3BEP as induction chemotherapy (CT) in nonseminomatous germ cell tumor (NSGCT) patients with poor prognosis

¹

,

Sergei Tjulandin

²

,

Д.А. Титов

³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

пациенты и методы1

Citation Types

Supporting

0

Mentioning

0

Contrasting

0

Unclassified

1

Year Published

2013

2013

2017

2017

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

0

Mentioning

0

Contrasting

0

Unclassified

1

Order By: Relevance

“…Комбинация ВЕР: цисплатин 20 мг / м 2 1-5 дни + этопозид 100 мг / м Все режимы проводились каждые 3 недели (за исклю чением режима аВЕР, применявшегося каждые 2 недели). Комбинации СВОР, ТВЕР, аВЕР применялись в рамках трех последовательных исследований II фаз [2,3,4].…”

Section: пациенты и методыunclassified

Treatment of patients with poor risk nonseminomatous germ cell tumors at advanced stages

Трякин¹,

Буланов³

et al. 2017

Zlokač. opuholi

View full text Add to dashboard Cite

No abstract

“…Комбинация ВЕР: цисплатин 20 мг / м 2 1-5 дни + этопозид 100 мг / м Все режимы проводились каждые 3 недели (за исклю чением режима аВЕР, применявшегося каждые 2 недели). Комбинации СВОР, ТВЕР, аВЕР применялись в рамках трех последовательных исследований II фаз [2,3,4].…”

Section: пациенты и методыunclassified

Treatment of patients with poor risk nonseminomatous germ cell tumors at advanced stages

Трякин¹,

Буланов³

et al. 2017

Zlokač. opuholi

View full text Add to dashboard Cite

No abstract

Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors

¹

,

²

,

³

et al. 2013

J Cancer Res Clin Oncol

View full text Add to dashboard Cite

CPOB and TBEP regimen were significantly associated with better outcome in pts with MNGCT. Age ≥ 24 years and size of the primary mediastinal tumor ≥ 19 cm were found as independent negative prognostic factors.

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.